Comprehensive Overview of Misoprostol: Applications, Dosage, and Safety
Misoprostol is primarily an ulcer medication, but it’s used in conjunction with mifepristone in 98% of all reported medication abortions in the US, according to the Guttmacher Institute. While the fate of mifepristone, also known as the abortion pill, plays out in US courts, health-care providers have another drug they can continue to use to offer medication abortion. Currently, the combination is “the gold standard for medication abortion in the US and elsewhere,” as noted by medical advisors for the National Abortion Federation.
Clinical Indications and FDA Approval
Misoprostol is currently only approved by the Food and Drug Administration (FDA) for the prevention and treatment of gastric ulcers resulting from chronic administration of nonsteroidal anti-inflammatory drugs (NSAIDS). However, there is significant use of misoprostol in obstetrics and gynaecology. There are currently multiple dedicated Misoprostol products on the global medication market. For example, Angusta® is a tablet of 25 µg misoprostol for oral induction of labour approved for marketing in the Nordic countries.
Dosage and Administration Guidelines
Regarding the use of misoprostol in obstetrics and gynaecology, the correct dosage varies greatly according to gestation, indication and route of administration. Using the correct dosage is vital for success and to prevent complications. Key international organisations promote the safe and effective use of misoprostol, with a focus on the needs of women in low resource settings.
Potential Adverse Effects
Misoprostol, like the vast majority of drugs, has potential adverse effects. The Summary of Product Characteristics (SPC) for Cytotec lists the potential problems and ways of avoiding complications. Users should be aware of the following potential issues:
- Pyrexia / Fever
- Shivering
- Hyperstimulation
- Teratogenicity (particularly concerning Misoprostol exposure during the first trimester of pregnancy)
Key Information Summary
The following table provides a summary of Misoprostol's primary characteristics and safety profile based on clinical data:
| Category | Details |
|---|---|
| FDA Approved Indication | Prevention and treatment of gastric ulcers (NSAIDS) |
| Common Off-Label Use | Medication abortion and induction of labour |
| Reported Side Effects | Pyrexia, Shivering, Hyperstimulation, Teratogenicity |
| Specific Product Example | Angusta® (25 µg tablet) |
Misoprostol exposure during the first trimester of pregnancy raises questions about whether the malformation risk varies depending on the indication. Detailed maps and lists of dedicated Misoprostol products can be accessed through international medical resources.